The Best Deals Today: College Football 26, Demon Slayer The Hinokami Chronicles 2, and More
We've rounded up the best deals for Sunday, September 7, below, so don't miss out on these limited-time offers.College Football
Archive for September 2025
Read More »
Wesley Yin-Poole
03:19
The Conjuring: Last Rites $187 Million Opening Weekend Is the Second Biggest Global Box Office Debut Ever for a Horror Film, Behind Only It
The Conjuring: Last Rites got off to a huge start at the box office, pulling in $187 million globally during
Wesley Yin-Poole
03:19
‘Criticism Isn’t Hate’ — Hollow Knight: Silksong Sparks Debate About Difficulty, Runbacks, and the Dreaded ‘Git Gud’ Comments
With Hollow Knight: Silksong’s huge launch in full swing, community debate about its qualities and flaws has gone back and
Gael Cooper
02:20
Today’s NYT Connections Hints, Answers and Help for Sept. 8, #820
Here are some hints and the answers for the NYT Connections puzzle for Sept. 8, No. 820...
Gael Cooper
02:20
Today’s Wordle Hints, Answer and Help for Sept. 8, #1542
Here are hints and the answer for today's Wordle for Sept. 8, No. 1,542...
Gael Cooper
02:20
Today’s NYT Strands Hints, Answers and Help for Sept. 8 #554
Here are hints and answers for the NYT Strands puzzle for Sept. 8, No. 554...
Augustine Catt
02:20
RFK Jr. wants to overhaul the country’s ‘vaccine court.’ Here’s what stands in his way.
The 40-year-old "vaccine court" relies on scientific evidence to determine whether a person experienced harm from a routine vaccination...
Augustine Damron
02:20
Meet the Chinese supercar that just smashed the EV speed record
Chinese EV maker BYD has designed and tested a supercar with a top speed that rivals the best gasoline cars...
Leigha Pecora
02:20
Scientific objectivity is a myth — here’s why
Cultural ideas are inextricably entwined with the people who do science, the questions they ask, the assumptions they hold and
Camellia Kazmierczak
02:19
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer
Patients diagnosed with recurrent or progressive extensive-stage small cell lung cancer (ES-SCLC) may benefit from treatment with ifinatamab deruxtecan (I-DXd),
